🇦🇺 From Australia · Endocrinology · Bariatric surgery
Obesity treatment in China for Australia patients
End-to-end pathway: visa, flight, hospital match, cost and length of stay — tailored for patients travelling from Australia for obesity care.
Pathway at a glance
About obesity
Obesity affects roughly 1 billion adults globally per WHO 2024 estimates. Treatment has been transformed by GLP-1 receptor agonists (semaglutide, tirzepatide) over the last 5 years, alongside the long-established surgical options (sleeve gastrectomy, RYGB, SADI). The price differential between US private pay and Chinese Class A international departments is among the largest of any condition area we serve.
The right treatment depends on BMI band, comorbidities, and prior treatment history. Most patients with BMI 30–35 without significant comorbidity benefit first from medication; BMI ≥ 35 with comorbidity or BMI ≥ 40 has the strongest evidence for bariatric surgery.
Why Australia patients travel to China
Australian patients commonly come for: orthopedic surgery (Medicare elective wait), stem cell therapy (TGA-restricted at home), cancer treatment (CAR-T, proton), dental tourism, and high-end executive physicals. Direct flights from major cities to Beijing/Shanghai.
Recommended cities for Australia patients
Shanghai (cardiology, orthopedic, oncology) and Beijing (PUMC) for major cases. Hong Kong / Shenzhen route popular for stem cell, dental and shorter trips.
Diagnostic workup at Class A centres
- Endocrinology consultation with comprehensive history
- HbA1c, fasting insulin, lipid panel, ALT/AST/GGT, eGFR, TSH
- Thyroid ultrasound (essential pre-GLP-1)
- BP, ECG, basic cardiovascular risk assessment
- BMI, waist circumference, body composition where relevant
Workup cost band: $400–$600 USD.
Treatment options
Semaglutide (Wegovy 2.4mg)
first-lineGLP-1 receptor agonist; weekly injection. China price USD 260–320/month vs USD 1,349/month US list.
Tirzepatide (Mounjaro / Zepbound)
first-lineDual GIP/GLP-1 receptor agonist; weekly injection. Higher %EWL than semaglutide in head-to-head trials. China price USD 280–340/month.
Sleeve gastrectomy
first-lineMost-performed bariatric procedure globally. China all-in USD 9,500–14,000 vs USD 18,000–28,000 US.
Roux-en-Y gastric bypass (RYGB)
first-lineStrong long-term durability and T2DM remission. China all-in USD 11,500–16,500.
SADI-S
selected casesSingle-anastomosis duodeno-ileal bypass; higher %EWL but technically more complex. China all-in USD 13,000–18,000.
Lifestyle intervention
first-lineFoundational for all bands. Sleep, nutrition, structured exercise, behavioural support.
Procedure cost from Australia
| Procedure | China (USD) | Australia (USD) | Length of stay |
|---|---|---|---|
| Bariatric (sleeve) | 9,500 – 14,000 | 16,000 – 24,000 | 12–18 d |
Visa pathway for Australia patients
Long Medicare wait times for elective surgery (knee/hip replacement, cataract) drive substantial Australian medical tourism to China. AUD purchasing power is favourable.
- 1
Receive invitation letter
Panda Touring Care issues hospital invitation letter within 3–5 business days.
- 2
Complete COVA online
Fill at cova.cs.mfa.gov.cn. Print and sign.
- 3
Submit at CVASC
Canberra, Sydney, Melbourne, Brisbane, or Perth visa centre with biometrics.
- 4
Collect visa
5–10 business days standard. Express 2–3 days.
Frequently asked
- Do Australia patients need a visa for obesity treatment in China?
- Yes — Australia citizens require M-Visa for medical treatment in China. Processing: 5–10 business days. Fee: AUD $109.50 standard · +AUD $80 expedited. Validity: Up to 3 years multi-entry possible.
- How long is the flight from Australia to China?
- 10–12 hours (SYD/MEL to PEK/PVG)
- Which Chinese cities are best for Australia patients seeking obesity care?
- Shanghai (cardiology, orthopedic, oncology) and Beijing (PUMC) for major cases. Hong Kong / Shenzhen route popular for stem cell, dental and shorter trips.
- How much can Australia patients save on obesity treatment in China?
- Typical Class A all-in pricing in China: $9,500–$14,000 USD. Equivalent in Australia: $16,000–$24,000 USD. Savings before travel: roughly 13–60%.
- What's the diagnostic workup for obesity at Class A international departments?
- Endocrinology consultation with comprehensive history; HbA1c, fasting insulin, lipid panel, ALT/AST/GGT, eGFR, TSH; Thyroid ultrasound (essential pre-GLP-1); BP, ECG, basic cardiovascular risk assessment; BMI, waist circumference, body composition where relevant.
Plan your obesity treatment from Australia
We arrange visa support, hospital match, written quote and door-to-door logistics from Australia. No obligation.